Two year save outcomes: 2.0 mg Ranibizumab for Recalcitrant Neovascular AMD

Research output: Contribution to journalLetter

13 Scopus citations
Original languageEnglish (US)
JournalOphthalmology
Volume120
Issue number9
DOIs
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Ophthalmology

Cite this